Trial Profile
A 2-Cohort, Multi-Centre, Randomised, Double Blind, Placebo Controlled 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses Of PF-00446687 On Erectile Function In Men Suffering From Erectile Dysfunction, Using 100 Mg Sildenafil As A Positive Control.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2011
Price :
$35
*
At a glance
- Drugs PF 446687 (Primary) ; Sildenafil
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors Pfizer
- 23 Mar 2009 New trial record